New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Amondys 45 casimersen Click here for more information |
Sarepta Therapeutics | An antisense oligonucleotide for treatment of Duchenne muscular dystrophy. |
|
Azstarys Serdexmethylphenidate/dexmethylphenidate Click here for more information |
Corium | A CNS stimulant for ADHD. |
|
Cabenuva cabotegravir and rilpivirine Click here for more information |
ViiV Healthcare | A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection. |
|
Cosela trilaciclib Click here for more information |
G1 Therapeutics | A kinase inhibitor to decrease the incidence of chemotherapy-induced myelosuppression. |
|
Evkeeza evinacumab-dgnb Click here for more information |
Regeneron | A monoclonal antibody for homozygous familial hypercholesterolemia. |
|
Fotivda tivozanib |
Aveo Pharm. | A kinase inhibitor for renal cell carcinoma. |
|
Jemperli dostarlimab-gxly Click here for more information |
GSK | A monoclonal antibody for endometrial cancer. |
|
Lupkynis voclosporin Click here for more information |
Aurinia Pharm. | A calcineurin-inhibitor immunosuppressant for active lupus nephritis. |
|
Nextstellis drospirenone / estetrol Click here for more information |
Mayne Pharma | A new combination progestin (drospirenone) and estrogen (estetrol) oral contraceptive. |
|
Nulibry fosdenopterin |
Origin Biosciences | A cyclic pyranopterin monophosphate to reduce risk of mortality in patients with molybdenum cofactor deficiency Type A. |
|
Pepaxto melphalan flufenamide Click here for more information |
Oncopeptides | An alkylating drug for relapsed or refractory multiple myeloma. |
|
Ponvory ponesimod Click here for more information |
Janssen | An oral sphingosine 1-phosphate receptor modulator for relapsing forms of multiple sclerosis. |
|
Qelbree viloxazine Click here for more information |
Supernus Pharm. | A selective norepinephrine reuptake inhibitor for ADHD. |
|
Tepmetko tepotinib Click here for more information |
EMD Serono | A kinase inhibitor for metastatic non-small cell lung cancer. |
|
Ukoniq umbralisib Click here for more information |
TG Therapeutics | A kinase inhibitor for marginal zone lymphoma and follicular lymphoma. |
|
Verquvo vericiguat Click here for more information |
Merck | A guanylate cyclase stimulator for patients with symptomatic chronic heart failure and ejection fraction <45%. |
|
Vocabria cabotegravir Click here for more information |
ViiV Healthcare | An HIV-1 integrase strand transfer inhibitor for short-term treatment of HIV-1 infection. |
|
Zegalogue dasiglucagon Click here for more information |
Zealand Pharma | A glucagon receptor agonist for severe hypoglycemia in patients with diabetes. |
|
Zynlonta loncastuximab tesirine-lpyl Click here for more information |
ADC Therapeutics | A monoclonal antibody for relapsed or refractory large B-cell lymphoma. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Kimyrsa oritavancin Click here for more information |
Melinta Therapeutics | New 1.2 g single-dose vial. |
|
Kloxxado naloxone Click here for more information |
Hikma Specialty | New higher strength (8 mg) nasal spray for emergency treatment of opioid overdose. |
|
Posimir bupivacaine Click here for more information |
Durect Corp. | New formulation local anesthetic for infiltration use. |
|
Roszet rosuvastatin / ezetimibe Click here for more information |
Althera Pharm. | A new combination statin and dietary cholesterol absorption inhibitor for hyperlipidemia. |
|
Zynrelef bupivacaine/meloxicam Click here for more information |
Heron Therapeutics | A combination local anesthetic/NSAID for soft tissue or periarticular instillation to produce postsurgical analgesia. |
| Brand/Generic | Company | Description |
|---|